Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology May 7, 2026 2:00 PM ...
Q4 2025 Earnings Call April 28, 2026 12:00 PM EDTCompany ParticipantsJeremy Skillington - CEO & DirectorLiam Tremble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results